510(k) K761008

LYMPHOCYTE TYPING, NEGATIVE CONTROL by Hyland Therapeutic Div., Travenol Laboratories — Product Code LGO

K761008 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LYMPHOCYTE TYPING, NEGATIVE CONTROL". The FDA issued a decision of Substantially Equivalent on April 6, 1977. The device falls under product code LGO (Test, Leukocyte Typing), a Class I device regulated under 21 CFR 864.7675. Hyland Therapeutic Div., Travenol Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 6, 1977
Date Received
November 2, 1976
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Test, Leukocyte Typing
Device Class
Class I
Regulation Number
864.7675
Review Panel
HE
Submission Type